AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2021
Jan 7, 2021
33341_dirs_2021-01-07_ed69457f-fda2-4ef1-90c5-aeae8a9b6a97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2021-01-05
Reporting Person: RAASCH JONA S (COO, NRC Health)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-05 | Employee Stock Option (right to buy) | $42.92 | A | 10485 | Acquired | 2031-01-05 | Common Stock (10485) | Direct |
Footnotes
F1: This option becomes fully exercisable on January 5, 2026.
More from NATIONAL RESEARCH CORP
Prospectus
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20